Towards quantum computing for clinical trial design and optimization: A perspective on new opportunities and challenges

Hakan Doga,M. Emre Sahin,Joao Bettencourt-Silva,Anh Pham,Eunyoung Kim,Alan Andress,Sudhir Saxena,Aritra Bose,Laxmi Parida,Jan Lukas Robertus,Hideaki Kawaguchi,Radwa Soliman,Daniel Blankenberg
2024-04-20
Abstract:Clinical trials are pivotal in the drug discovery process to determine the safety and efficacy of a drug candidate. The high failure rates of these trials are attributed to deficiencies in clinical model development and protocol design. Improvements in the clinical drug design process could therefore yield significant benefits for all stakeholders involved. This paper examines the current challenges faced in clinical trial design and optimization, reviews established classical computational approaches, and introduces quantum algorithms aimed at enhancing these processes. Specifically, the focus is on three critical aspects: clinical trial simulations, site selection, and cohort identification. This study aims to provide a comprehensive framework that leverages quantum computing to innovate and refine the efficiency and effectiveness of clinical trials.
Quantum Physics,Emerging Technologies
What problem does this paper attempt to address?
This paper discusses the issues of clinical trial design and optimization in the drug discovery process. Currently, the success rate of clinical trials is low, mainly due to the insufficient development of clinical models and trial design. The paper proposes the use of quantum computing to improve these processes, with a particular focus on clinical trial simulation, trial site selection, and queue identification. Quantum computing utilizes principles of quantum mechanics such as entanglement, superposition, and interference, to potentially enhance certain computational efficiencies. The paper reviews traditional classical computing methods, pointing out their challenges, and proposes workflows for quantum optimization and quantum machine learning methods to improve clinical trial design. The authors believe that by optimizing these key aspects, trial efficiency and effectiveness can be improved, drug development costs can be reduced, and ultimately the quality of patient care can be enhanced. The paper also discusses major challenges in clinical trials, such as inaccurate patient queue selection and improper trial site selection, and highlights the potential of quantum computing in addressing these issues.